Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Dermatologic 2Other 1Gastrointestinal 1

Conditions

Obesity 56Mucositis 22Polycystic Ovary Syndrome 20Neoplasms 17Sexual Dysfunction, Physiological 15Breast Neoplasms 14Dyspnea 11Head and Neck Neoplasms 10Motor Activity 8Colorectal Neoplasms 8Rectal Neoplasms 6Prostatic Neoplasms 6Diabetes Mellitus 6Stomatitis 5Pain 5Lung Neoplasms 5Constipation 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Obesity, Morbid 4Infertility 4Depression 4Colonic Neoplasms 4Xerostomia 3Weight Loss 3Pulmonary Disease, Chronic Obstructive 3Osteoporosis 3Metabolic Syndrome 3Insulin Resistance 3Heart Failure 3Eczema 3

Interventions

golotimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mouth Diseases × Other × Clear all
NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡